News
News

The latest updates from AFAR.

Longevity and Health of U.S. Presidential Candidates: New White Paper by AFAR Board Member S. Jay Olshansky, PhD

Jul 26
2019

Longevity and Health of U.S. Presidential Candidates: New White Paper by AFAR Board Member S. Jay Olshansky, PhD

    AFAR is pleased to release the white paper, Longevity and Health of U.S. Presidential Candidates for the 2020 Election. AFAR board member S. Jay Olshansky, Ph.D., is lead author of the white paper, which summarizes the first-ever scientific study estimating the longevity and survival probabilities of U.S. presidential candidates in the 2020 election. Olshansky, a leading researcher on aging at the University of Illinois at Chicago School of Public Health, and his colleagues used data from national vital statistics to estimate lifespan, healthspan, disabled lifespan, and four- and eight-year survival probabilities for U.S. citizens with attributes…


View MoreREAD MORE


Board Member in the News: Steven Austad’s latest PBS Next Avenue Column, “What Space Flight Teaches Us About Aging

Jul 26
2019

Board Member in the News: Steven Austad’s latest PBS Next Avenue Column, “What Space Flight Teaches Us About Aging"

  On July 24, 2019, Next Avenue published the latest column by AFAR Scientific Director Steven N. Austad, PhD. In commemoration of the fiftieth anniversary of the Apollo 11 moon landing, Dr. Austad explains what we have learned about aging by studying older astronauts. The article also references the 1998 mission by late AFAR Board Member John Glenn. In addition to serving as AFAR’s Scientific Director, Dr. Austad is a distinguished professor and Chair of the Department of Biology at the University of Alabama at Birmingham, as well as Co Principle-Investigator of the Nathan Shock Centers of Excellence in the Basic Biology…


View MoreREAD MORE


Experts in the News: Thomas Perls and S. Jay Olshansky Explain Why Alternative Medicine Will Not Replace Research in Medscape

Jul 22
2019

Experts in the News: Thomas Perls and S. Jay Olshansky Explain Why Alternative Medicine Will Not Replace Research in Medscape

  On July 11, 2019, Medscape featured insights of AFAR experts Thomas Perls, MD, and S. Jay Olshansky, PhD in an article debunking alternative medicine promoted by Mr. Robert Ledda and Cenegenics Medical Institute. In the article, Dr. Perls and Olshansky defend research backed by clinical trials to disprove the alternative medicine Ledda promotes. The article also mentions the AFAR-managed TAME Trial as an example of future research that may provide the data often desired by those who seek out alternative medicine. Dr. Perls is a 1998 Paul B. Beeson Emerging Leaders Career Development Award recipient. He is the Founder and Director of…


View MoreREAD MORE


Grantee in the News: Eric Lieberman Greer's research on Translational Epigenetic Inheritance of Longevity in PLOS Genetics

Jul 22
2019

Grantee in the News: Eric Lieberman Greer's research on Translational Epigenetic Inheritance of Longevity in PLOS Genetics

  On July 8, 2019, PLOS Genetics published research co-authored by Eric Lieberman Greer, PhD, on transgenerational epigenetic inheritance of longevity. Dr. Greer is a 2016 AFAR Research Grant recipient. This funding supported the published research. He is an Assistant Professor of Pediatrics at Boston Children’s Hospital and Harvard Medical School. Read the research, “The demethylase NMAD-1 regulates DNA replication and repair in the Caenorhabditis elegans germline,” here.


View MoreREAD MORE


Grantee in the News: Thomas Perl on Centenarian Research in TODAY

Jul 22
2019

Grantee in the News: Thomas Perl on Centenarian Research in TODAY

  On July 8, 2019, TODAY featured insights AFAR expert Thomas Perls, MD, MPH, FACP, in an article about Alelia Murphy, the oldest living American. Ms. Murphy turned 114 on July 6, 2019, and the article explores the phenomenon behind supercentenarians, or people who are 110 years old or older. Dr. Perl explains the behaviorial and lifestyle choices that influence living into your 80s and beyond. Dr. Perls is a 1998 Paul B. Beeson Emerging Leaders Career Development Award recipient. He is the Founder and Director of the New England Centenarian Study and a Professor of Medicine at Boston University’s School of Medicine. Read the…


View MoreREAD MORE


News from the Field: International Perspectives on Geroscience Meetings kick off in Shenzhen and San Francisco

Jul 17
2019

News from the Field: International Perspectives on Geroscience Meetings kick off in Shenzhen and San Francisco

  AFAR is pleased to help coordinate a series of International Perspectives on Geroscience Meetings, organized by the Nathan Shock Centers of Excellence in the Basic Biology of Aging in collaboration with a range of institutional partners in host cities. A range of AFAR experts are presenting at the meetings and serving as co-chairs and lead organizers.   China The first meeting kicked off in Shenzhen, China from May 24-25, 2019 at the Marco Polo Hotel. Co-Chairs of the Steering Committee included AFAR experts Sean X. Leng, MD, PhD, and Brian Kennedy, PhD. Topics included principles of geroscience,…


View MoreREAD MORE


Grantee in the News: Luigi Fontana explores the Health Benefits of Small Caloric Restrictions in The Lancet Diabetes & Endocrinology

Jul 15
2019

Grantee in the News: Luigi Fontana explores the Health Benefits of Small Caloric Restrictions in The Lancet Diabetes & Endocrinology

On July 11, 2019, The Lancet Diabetes & Endocrinology published research coauthored by AFAR expert Luigi Fontana, MD, PhD, that suggests small caloric restrictions of approximately 300 calories per day in young and middle-aged individuals may lead to long-term health benefits. Dr. Fontana is a 2009 Glenn/AFAR Breakthroughs in Gerontology Award recipient and 2016 Vincent Cristofalo Rising Star Award in Aging Research recipient. He is a Professor, Leonard P. Ullman Chair in Translational Metabolic Health, and Director of the Healthy Longevity Research and Clinical Program at the University of Sydney. Read the study, “2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes…


View MoreREAD MORE


Board Member in the News: Rudolph Tanzi in Neuron on the Role of Gene Crosstalk in Alzheimer’s Disease

Jul 15
2019

Board Member in the News: Rudolph Tanzi in Neuron on the Role of Gene Crosstalk in Alzheimer’s Disease

  On July 10, 2019, Neuron published research by AFAR expert Rudolph E. Tanzi, PhD, that explores how "crosstalk" between the genes TREM2 and CD33 might play a role in neuroinflammation and the origin of Alzheimer's disease. Dr. Tanzi  is an AFAR board member. He is the Director of the Genetics and Aging Research Unit at Massachusetts General Institute for Neurodegenerative Disease, and a Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School. The study, “TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease,” will appear in print on…


View MoreREAD MORE


Grantee in the News: Domenico Praticò’s research on VPS35 Preventing Toxic Tau Buildup in Molecular Psychiatry

Jul 15
2019

Grantee in the News: Domenico Praticò’s research on VPS35 Preventing Toxic Tau Buildup in Molecular Psychiatry

On July 9, 2019,  Molecular Psychiatry published a study co-authored by AFAR expert Domenico Praticò, MD, that explores how the molecule VPS35 may play a vital role in helping to prevent the buildup of toxic tau, a protein that tends to accumulate in the brains of people with Alzheimer’s disease. This is the first study to show that VPS35 has a role in tauopathy. Dr. Praticò is a 1997 and 1999 AFAR Research Grant recipient. He is the Scott Richards North Star Charitable Foundation Chair for Alzheimer’s Research, and a Professor and Director of the Alzheimer&rsquo…


View MoreREAD MORE


Experts in the News: Seven AFAR experts co-author JAGS article on Creating the Next Generation of Translational Geroscientists

Jul 15
2019

Experts in the News: Seven AFAR experts co-author JAGS article on Creating the Next Generation of Translational Geroscientists

On July 9, 2019, the Journal of the American Geriatrics Society published an article co-authored by seven AFAR experts, mapping the need to prepare clinical investigators to conduct geroscience trials. AFAR experts contributing to the article include: Steven N. Austad, PhD: Dr. Austad is AFAR’s Scientific Director and a distinguished Professor and Chair of the Department of Biology at the University of Alabama at Birmingham, as well as Co Principle-Investigator of the Nathan Shock Centers of Excellence in the Basic Biology of Aging Coordinating Center. Nir Barzilai, MD: Dr. Barzilai is AFAR’s Deputy Scientific Director, a 1994 AFAR Research…


View MoreREAD MORE


Grantee in the News: Thomas Gill editorial on Translational Geroscience in JAGS

Jul 15
2019

Grantee in the News: Thomas Gill editorial on Translational Geroscience in JAGS

  On July 9, 2019, the Journal of the American Geriatrics Society published an editorial by AFAR expert Thomas M. Gill, MD, highlighting the efforts AFAR has made to expand and fund the field of geroscience research. In his editorial, Dr. Gill notes how a variety of AFAR grant programs help increase support for medical students and junior faculty while simultaneously strengthening public-private partnerships. He also explains how the upcoming TAME trials will attract researchers to geroscience. In conclusion, he highlights AFAR’s role as an administrative coordinating center, stating that “..[they are] ideally positioned to advance research and training…


View MoreREAD MORE


Grantee in the News: Dena Dubal in Nature Medicine on her Journey to Biomedical Research

Jul 08
2019

Grantee in the News: Dena Dubal in Nature Medicine on her Journey to Biomedical Research

On July 3, 2019, Nature Medicine featured an article by AFAR expert Dena Dubal, MD, PhD, exploring her personal journey to a career in biomedical research. Dr. Dubal is a 2015 AFAR Research Grant for Junior Faculty recipient, 2009 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, and 1998 Glenn/AFAR Scholarships for Research in the Biology of Aging recipient. She is an assistant professor of neurology at the University of California San Francisco. Read the feature  – “Pathways to brain resilience” – here. 


View MoreREAD MORE


UPCOMING WEBINAR: August 6 :  Genetic Diversity in Mouse Models & Alzheimer’s Precision Medicine with Catherine Kaczorowski

Jul 08
2019

UPCOMING WEBINAR: August 6 : Genetic Diversity in Mouse Models & Alzheimer’s Precision Medicine with Catherine Kaczorowski

  As Coordinating Center of the Nathan Shock Centers of Excellence in the Basic Biology of Aging program of the NIA, AFAR is pleased to host:     WEBINAR: Incorporating Genetic Diversity in Mouse Models and the Potential for Precision-Medicine for Alzheimer’s   Tuesday, August 6, 2019 2-3pm Eastern (11am-12pm Pacific)   Catherine Kaczorowski, PhD of the Nathan Shock Center at the Jackson Lab has recently found that incorporating genetic diversity into modeling Alzheimer’s disease in mice resulted in greater overlap with the genetic, molecular, and clinical features of this pervasive human disease. This is the…


View MoreREAD MORE


AFAR in the News: MMAAP Foundation First International Perspectives on Geroscience Meeting Held in

Jul 17
2019

AFAR in the News: MMAAP Foundation First International Perspectives on Geroscience Meeting Held in

It is clear that the field of geroscience is poised to become an important area of focus in biomedicine in the future. But there is considerable work to be done in order to bring the field forward, bridging the gap and increase our understanding of the molecular and cellular underpinnings of aging that make it the main risk factor for disease and disability. In 2019, a series of international meetings, with support from the Nathan Shock Centers Coordinating Center, will aim to increase and enhance our understanding of geroscience concepts, and to encourage researchers around the globe to integrate…


View MoreREAD MORE


AFAR in the News: MMAAP Foundation First International Perspectives on Geroscience Meeting Held in Shenzhen

Jul 17
2019

AFAR in the News: MMAAP Foundation First International Perspectives on Geroscience Meeting Held in Shenzhen

  It is clear that the field of geroscience is poised to become an important area of focus in biomedicine in the future. But there is considerable work to be done in order to bring the field forward, bridging the gap and increase our understanding of the molecular and cellular underpinnings of aging that make it the main risk factor for disease and disability. In 2019, a series of international meetings, with support from the Nathan Shock Centers Coordinating Center, will aim to increase and enhance our understanding of geroscience concepts, and to encourage researchers around the globe to integrate these…


View MoreREAD MORE


Annual Report: Big Questions, Breakthrough Science

Jul 08
2019

Annual Report: Big Questions, Breakthrough Science

  The American Federation for Aging Research is proud to release our 2018 annual report, “Big Questions, Breakthrough Science." In the 2018 Annual Report, we focus on three of the big questions most commonly asked about aging research today: Will there be a pill to slow aging? What can I do now to stay healthier, longer? Is it ever too late to improve your health? To answer, we highlight a small sample of the breakthrough science led by AFAR investigators. AFAR President-elect James L. Kirkland, MD, PhD, AFAR President and former Beeson Scholar Mark S. Lachs, MD, MPH, and AFAR Scientific…


View MoreREAD MORE




BACK TO TOPBACK TO TOP